← Open Payments lookup

DAVIDSON EWUZIE: Open Payments

NPI 1508406018 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$752 in 37 payments from 13 companies in 2025. Trend: 2023 $860 · 2024 $571 · 2025 $752

Food & beverage: $752
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$148
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$141
Lundbeck LLC4$82
Axsome Therapeutics, Inc.3$63
Vanda Pharmaceuticals Inc.2$49
Alkermes, Inc.2$47
Supernus Pharmaceuticals, Inc.2$46
Neurocrine BioSciences, Inc.2$43
ABBVIE INC.2$33
Teva Pharmaceuticals USA, Inc.2$32

Products named: REXULTI, CAPLYTA, Auvelity, FANAPT, ARISTADA, Qelbree, INGREZZA, VRAYLAR.

Industry payments across TX — which companies pay providers there.